NCT06109974Completed
Evaluate the Accuracy of a COPD Screening Algorithm Model
Evaluation of an Algorithm That Can Detect COPD by Intelligent Terminal Device
Source: ClinicalTrials.gov · Last updated 23 Jan 2024
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, we have established an algorithm that can detect and infer the severity of COPD from physiological parameters and audio data collected by wearable devices, and in this stage, we aim to evaluate the accuracy of this algorithm.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 400 (actual)
- First submitted
- 25 Oct 2023
- Start date
- 13 Sept 2022
- Primary completion date
- 4 Jan 2024
- Lead sponsor
- Peking University First Hospital
- Diseases
- COPD
- NCT number
- NCT06109974
What you commit to
- Study type: Observational
- Participants enrolled: 400
- From 13 Sept 2022 to the primary completion date, 4 Jan 2024
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosed with chronic respiratory diseases other than COPD, such as asthma, lung cancer, active tuberculosis, bronchiectasis and diffuse lung diseases (interstitial pneumonia, occupational lung disease, sarcoidosis, etc.).
- lobectomy and/or lung transplantation, pleural disease.
- Dual upper limb pigmentation or abnormal blood supply (occlusion, thrombosis, trauma, etc.).
Lab values
- Complicated with serious underlying diseases, including severe mental illness, intellectually impaired diseases, neurological disease (resulting in limb movement disorder), malignant tumor (PS score \> 2), chronic liver disease (transaminase \> 3 times the upper limit of normal), heart failure (NYHA\> Grade 3), autoimmune disease, chronic kidney disease (CKD-5), unstable coronary artery disease, arrhythmia (atrial fibrillation, atrial flutter, severe ventricular arrhythmia), congenital heart disease, pulmonary hypertension, etc., or life expectancy of less than 6 months.
Other
- Malnutrition (BMI\<18 kg/m2).
- Bilateral wrist and hand edema, wrist soft tissue injury, inability to wear a watch/bracelet due to incomplete skin.
Who the study is looking for
- Over the age of 18, no gender restrictions.
- Participants at high risk of COPD (COPD-PS score ≥5).
- Able to carry out daily activities and wear wearable devices.
- Willing to participate in the study, willing to comply with the study protocol, and have the ability to sign informed consent.
- Possess mobile communication equipment, which can meet the requirement of installing wearable device applications and recording function.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangfa Wang Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Shichahai community health service center Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| The Hospital of Changping District Beijing Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Baizhifang Community Health Service Center of Xicheng District Beijing Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Civil Aviation General Hospita Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.